TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: IIEF-5 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in mean visual analogue scales (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lung function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of moderate/severe COPD exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with study design and conduct
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cognitive test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: BLS sequence performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of ventilations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI threshold of 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in low frequency of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in high frequency of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: primary CVD outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cervical position error
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of acute heart failure
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of PPD at 1 week and 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulated dosage of sufentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Listening/communication abilities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: FMD in the distal RA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: pooled clinical response at the TOC visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiologic eradication of pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Zero all bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate to severe rectal and bladder complications
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative chronic groin pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities Scale for Kids-performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health care cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: patient cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response rate on PANSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: significantly differentially expressed genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Satisfaction with anesthesia effect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SBP, HR, and RR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction of the study group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction of doctors
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peak plasma methylphenidate concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of absorption (area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global health (QoL indicator)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxidative stress profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDMT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: average heart rate response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total blood pressure response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in SALT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade V improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage reductions in observable focal seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 50% responder rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average pneumococcal antibody geometric mean concentrations (AB GMCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: First peak KAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee flexion at heel-strike
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically relevant nonmajor bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of stomatitis episodes grade ≥2
Endpoint domain: Adverse events/effects
Primary endpoint: Vocabulary size at 18 and 24 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Anxiety scores (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: diagnostic ascertainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDP targets achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: risk of wound infection within 30 days post-operatively
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence rates at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Arrival for scheduled surgical appointment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Grade 3–4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Mean absolute glucose (MAG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage time in glucose target 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abdominal VFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in variant allele frequency (VAF) of pathogenic SNVs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Central Subfield Thickness (CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Incidence of Intraocular Pressure (IOP) elevations
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of patients demonstrating weight reduction of at least 5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence density rates of KPC‐producing enterobacteria HAI
Endpoint domain: Adverse events/effects
Primary endpoint: dual-task gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FRT (Functional Reach Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRT (Clinical Reach Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lequesne total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Activities of daily living (ADL) subscale of Lequesne
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Iron intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: success rate of anesthesia maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superficial punctate keratitis resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: conjunctival clinical signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: vertical graft shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRT adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EELI decrease during apnoeas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2 drop after apnoeas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HR drop after apnoeas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arthritis pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety mean scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical-component health-related quality of life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cooperative behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Acquisition of Achromobacter xylosoxidans
Endpoint domain: Adverse events/effects
Primary endpoint: Acquisition of multidrug-resistant Pa
Endpoint domain: Adverse events/effects
Primary endpoint: MCV coverage rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCV wastage rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Willingness to open a vial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average vertical bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: average horizontal bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: accuracy of the final actual augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adhesion results (bond strength and nanoleakage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microhardness values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical competency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TGFB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in bacterial viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: proportion of deaths with an indeterminate cause
Endpoint domain: Mortality/survival
Primary endpoint: odds of emotional distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall patient satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall family satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient's anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PP rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS of maximal headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PHQ9 (depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GAD7 (anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PEmax improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6MWT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Health utility value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TWES-scores for occlusal/incisal surfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arterial pH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HCO3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postprandial glucose (PPG) excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OME consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral infarction risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: composite pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: somatic menopausal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in validated cardiovascular risk scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive rate of mNGS pathogen detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Effective rate after 2 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of serum IL-6, PCT, and hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ACTT scale scores at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain at 12 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: i-Ready reading test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOG severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily living step counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOG‐provoking test time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in INa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of FS development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: costs for the index CABG procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: follow-up costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: disaster nursing competence levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication counts
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: engagement with legislators and governors regarding EBIs
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: inappropriate termination of programs in work unit
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of depression (HAM-D score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of depression (BDI score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate hypoxia reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hospitalized stable patients
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in hematologic toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in HRQoL related to fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in HRQoL related to physical wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in HRQoL related to functional wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Radiographic progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total BDI scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients reaching or exceeding the PHQ‐9 MCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients reaching or exceeding the MADRS MCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful penetration (SEP2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful intercourse (SEP3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived self-efficacy in raising the issue of weight
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived self-efficacy in answering questions or concerns
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sputum excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function (FEV1, FVC, FEV1/FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CAT score and Borg score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: right-hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sit-and-reach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: behavioral intention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: first step pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAOS questionnaire subscales
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative survival (%)
Endpoint domain: Mortality/survival
Primary endpoint: Marginal defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sedentary behaviour across the whole school day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of serious bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: computation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean NRS score at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Patient-perceived benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in genetics-genomics knowledge of nursing students
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ESD procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of perforation
Endpoint domain: Adverse events/effects
Primary endpoint: return to normal daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NRSR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Spontaneous menses resumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Regular menstrual cycles establishment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Plasma cortisol concentrations after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increase in plasma cortisol before and after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Level of adrenocorticotropin before and after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: fatal overdoses
Endpoint domain: Mortality/survival
Primary endpoint: hospitalizations unrelated to the study
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Increase in maximum mouth opening (MMO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in TMJ noises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of red meat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence rates of osteoporotic fractures
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in inflammatory bowel disease-associated metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of all-cause death (in-hospital and within 1 year)
Endpoint domain: Mortality/survival
Primary endpoint: antigen-specific B and T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinical responses lasting longer than 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer biopsies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: increase in cancer yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: over-diagnosis of clinically insignificant prostate cancer avoided
Endpoint domain: Adverse events/effects